News
-
-
-
PRESS RELEASE
EQS-Adhoc: Viromed Medical AG will not acquire ActivCell Group AG and is focusing on another strategic option with greater added value
Viromed Medical AG cancels acquisition of ActivCell Group AG, exploring more valuable strategic options. Focus shifts to advancing innovative medical device ViroCAP -
-
-
-
-
-
PRESS RELEASE
EQS-Adhoc: Viromed Medical AG plans to acquire all shares of ActivCell Group AG by way of a capital increase against contribution in kind with exclusion of subscription rights
Viromed Medical AG plans to acquire all shares of ActivCell Group AG by capital increase excluding subscription rights, strategically expanding product portfolio -
